NeoImmuneTech KRX:950220KOSDAQ

네오이뮨텍 · Korean news coverage and regulatory filings, organized.

Articles, 24h1
Articles, 7 days8
DART filings, 7 days1
Articles tracked36since Sep 11

NeoImmuneTech (네오이뮨텍) appeared in 8 Korean news articles and 1 DART filing over the past seven days. Coverage peaked on Nov 12 with 7 articles. The most common catalyst was contracts & orders (4). It was most often mentioned alongside Curocell and i-SENS.

Filing signals 4 quarters of losses Screener

NeoImmuneTech today: up or down?

No sign-up, one tap a day. These numbers show what visitors think and are not investment advice.

Upcoming dates as filed

  • Mar 31 Annual report filing deadlinein 134 days · period ending Dec 2026

Dates NeoImmuneTech stated in its DART filings. A conversion period opening does not mean new shares appear that day; bondholders must request conversion.

NeoImmuneTech quarterly results consolidated, KRW

QuarterRevenueYoYOperating profitNet income
Q3 2026 check units₩3m–−₩3m−₩3m
Q2 2026₩1m+4383.8%−₩3m−₩0m
Q1 2026₩0m+3847.7%−₩4m−₩5m
Q4 2025 derived₩0m–−₩4m−₩7m
Q3 2025₩0m-98.4%−₩3m−₩4m
Q2 2025₩0m–−₩5m−₩5m
Q1 2025₩0m–−₩6m−₩6m
Q4 2024 derived check units−₩1m–−₩6m−₩6m

Q3 2026 Korean earnings rankings →

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

NeoImmuneTech top stories 2 weeks, by number of outlets

  1. 1
    Neoimmuntech Q3 cumulative sales 6.5 billion won, up 11,612% year-on-year
    2 outlets · 2 articlesFirst report Nov 12 08:56 뉴스타운Earnings
  2. 2
    Neoimmune Tech Q3 cumulative sales 6.5 billion won…reflects technology transfer and US pharmaceutical sales
    1 outlets · 1 articlesFirst report Nov 12 10:07 메디컬투데이Licensing deal
  3. 3
    Sales surge 11,612%... Neoimmuntech gains wings with technology export and direct sales
    1 outlets · 1 articlesFirst report Nov 12 14:39 한스경제Licensing deal
  4. 4
    NeoImmuneTech expands revenue base through technology transfer and US pharmaceutical sales
    1 outlets · 1 articlesFirst report Nov 12 08:09 메디파나뉴스Licensing deal
  5. 5
    Neoimmunetech 3Q revenue surges with US technology transfer and drug sales
    1 outlets · 1 articlesFirst report Nov 12 08:45 PRESS9Licensing deal
  6. 6

Latest NeoImmuneTech news Korean headlines